statut,statut_label,statut_name,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,results_1y,results_3y,results,intervention_type
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT03166969,,,2013,,HOLTER-21J,False,False,True,PROCEDURE
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01916785,,,2013,A PROSPECTIVE RANDOMIZED PHASE II STUDY EVALUATING THE OPTIMIZATION OF THE RESIDUAL PLASMATIC LEVEL OF DASATINIB (SPRYCEL¬Æ) IN PATIENTS NEWLY DIAGNOSED WITH CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML).,OPTIM-DASA,False,False,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02963545,,,2016,Simultaneous Assessments of Serotonin and Kynurenine Pathways Parameters in Patients Shortly (Less Than 4 Hours and a Half) After the Onset of a Cerebral Infarction,,False,False,False,BIOLOGICAL
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02882568,,,2016,Analysis of Immune Response In Bacterial Infection of Obese Subject,ARIIBO,False,False,False,BIOLOGICAL
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02888964,,,2016,A Study to Assess Efficacy and Safety of Pioglitazone as Add-On Therapy to Imatinib Mesylate in CP-CML Patients in Major Molecular Response,ACTIM,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02896842,,,2016,A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate (Glivec¬Æ) Plasmatic Through Level in Patients Newly Diagnosed With Chronic Phase Chronic Myelogenous Leukaemia (CP-CML).,OPTIMIMATINIB,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02888990,,,2016,An Open Label Phase II Study to Evaluate the Efficacy and Safety of Induction and Consolidation Therapy With Dasatinib in Combination With Chemotherapy in Patients Aged 55 Years and Over With Philadelphia Chromosome Positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL).,EWALLPH01,False,False,False,DRUG
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT02883959,,,2016,,Painkiller,False,True,True,OTHER
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT01946750,,,2017,,SERODIFF,False,False,False,BIOLOGICAL
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02896374,,,2017,Normal and Abnormal Event Related Potentials During Attribution of Intentions to Others and Resolution of Emotional Conflicts in Schizophrenia,SERC,False,False,False,BEHAVIORAL
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02901015,,,2017,Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning (EVACO),EVACO,False,False,False,BEHAVIORAL
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03115242,,,2017,Contrast Enhanced Ultrasound of Carotid Plaque in Acute Ischemic Stroke,CUSCAS,False,False,False,OTHER
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT02349074,,,2019,Digestive ENdoscopy afTeR Out-of-hospitAl Cardiac arresT,ENTRACT,False,True,True,PROCEDURE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02894177,,,2020,Is Transcutaneous Carbon Dioxide Pressure (tcPCO2) Monitoring During Spontaneous Breathing Trials Useful to Predict Extubation Failure in Mechanically Ventilated Patients in the ICU?,tcPCO2,False,False,False,PROCEDURE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03030482,,,2020,Evaluation of Touch Massage on Anxiety in Critically Ill Patients : a Randomised Controlled Trial Study (REaLAX),REaLAX,False,False,False,PROCEDURE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT04363528,,,2021,Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,COVIDOP-DVT,False,False,False,OTHER
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03973385,,,2022,Evaluation of Efficacy of Cryotherapy for Skin Anesthesia During Arterial Puncture for Blood Gas in Critically Ill Patients. SNOW Study,SNOW,False,False,False,DEVICE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02473146,,,2023,Etude Exploratoire randomis√©e Comparant le Traitement Par Gemtuzumab Ozogamicin /Cytarabine au Traitement Standard Par Idarubicine/Cytarabinechez Les Sujets √¢g√©s de 60 √† 80 Ans et pr√©sentant Une LAM et un Caryotype Non d√©favorable,ALFA1401,False,False,False,DRUG
